SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The March 2024 quarter revenue stood at Rs. 1537.48 millions, up 21.09% as compared to Rs. 1269.72 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2024 is Rs. -9.89 millions as compared to Net Loss of Rs. -49.96 millions of corresponding quarter ended March 2023OP of the company witnessed a marginal growth to 147.42 millions from 79.69 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1537.48 1269.72 21.09 4581.81 6281.66 -27.06 4581.81 6281.66 -27.06
Other Income 20.32 25.66 -20.81 55.84 130.36 -57.16 55.84 130.36 -57.16
PBIDT 147.42 79.69 84.99 -3.19 893.00 -100.36 -3.19 893.00 -100.36
Interest 66.80 64.05 4.29 252.44 207.40 21.72 252.44 207.40 21.72
PBDT 80.62 15.64 415.47 -255.63 685.60 -137.29 -255.63 685.60 -137.29
Depreciation 90.22 77.75 16.04 363.13 337.12 7.72 363.13 337.12 7.72
PBT -9.60 -62.11 -84.54 -618.76 348.48 -277.56 -618.76 348.48 -277.56
TAX 0.29 -12.15 -102.39 -148.89 93.29 -259.60 -148.89 93.29 -259.60
Deferred Tax 0.29 -1.91 -115.18 -148.89 93.29 -259.60 -148.89 93.29 -259.60
PAT -9.89 -49.96 -80.20 -469.87 255.19 -284.13 -469.87 255.19 -284.13
Equity 196.09 196.06 0.02 196.09 196.06 0.02 196.09 196.06 0.02
PBIDTM(%) 9.59 6.28 52.77 -0.07 14.22 -100.49 -0.07 14.22 -100.49

Astec Lifesciences Share Price

726.50 -22.90 (-3.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×